A case of arthritis under pembrolizumab.
Rheumatology department, Maison-Blanche hospital, Reims university hospitals, 45, rue Cognacq-Jay, 51092 Reims cedex, France; EA 3797, faculty of medicine, university of Reims Champagne-Ardenne, 51095 Reims, France. Electronic address: jhsalmon@chu-reims.fr.
Jean-Hugues
JH
Salmon
Rheumatology department, Maison-Blanche hospital, Reims university hospitals, 45, rue Cognacq-Jay, 51092 Reims cedex, France.
Isabelle
I
Lambrecht
Rheumatology department, Maison-Blanche hospital, Reims university hospitals, 45, rue Cognacq-Jay, 51092 Reims cedex, France.
Pascal
P
Brochot
Dermatology department, Robert-Debré hospital, Reims university hospitals, 51092 Reims, France.
Florent
F
Grange
D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D001168:Arthritis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D009361:Neoplasm Invasiveness / Q000473:pathology; D009362:Neoplasm Metastasis; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D028761:Withholding Treatment
D061067:Antibodies, Monoclonal, Humanized; C582435:pembrolizumab
Adverse effects; Arthritis; Pembrolizumab